The deadline to claim credit for the ATA Annual Meeting has past.
Continuing Medical Education (CME) AMA PRA Category 1 Credits™ may be claimed by contacting Ellen Ricker of the University of Colorado School of Medicine (ATA’s joint CME provider) at ELLEN.RICKER@CUANSCHUTZ.EDU.
Unfortunately, the November 25 deadline to claim American Board of Internal Medicine (ABIM) Maintenance of Certification (MOC) points was firm. MOC credit can no longer be claimed for the ATA Annual Meeting.
IMPORTANT:
- CME certificates for those individuals that completed the online EVALUTION SURVEY were distributed electronically to the email address provided on your evaluation survey.
- MOC credits for those individuals that completed the online EVALUTION SURVEY were reported to the ABIM on December 6, 2019. If you completed the survey, you should now see the credits you claimed reflected in your ABIM record. Please note that ATA credits will not appear in delinquent ABIM accounts until the account has been made current.
ACCREDITATION
This activity was planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The University of Colorado School of Medicine and the American Thyroid Association. The University of Colorado School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
DESIGNATION
89th Annual Meeting of the American Thyroid Association® // October 30 – November 3, 2019
The University of Colorado School of Medicine designated this live activity for a maximum of 29.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 29.25 medical knowledge MOC points in the American Board of Internal Medicine (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
2019 E. Chester Ridgway Trainee Conference & 89th Annual Meeting of the ATA//October 30 – November 3, 2019
The University of Colorado School of Medicine designated this live activity for a maximum of 39.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 39.25 medical knowledge MOC points in the American Board of Internal Medicine (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
2019 Endocrine Neck Advanced Ultrasound Course //October 30, 2019
The University of Colorado School of Medicine designated this live activity for a maximum of 7.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 7.75 medical knowledge MOC points in the American Board of Internal Medicine (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Target Audience
With attendance of over 1,600 healthcare professionals, the 89th Annual Meeting of the ATA brought bring top researchers and practitioners in thyroidology with interests in the fields of endocrinology, oncology, nuclear medicine, internal medicine, surgery, pathology, cytology, biology and related areas.
Educational Design
The 89th Annual Meeting of the ATA featured innovative talks on clinically relevant topics, “discussion/ debate” workshops, interactive sessions, state-of-the-art presentations and unparalleled collegiality in a multidisciplinary setting.
Upon completion of this conference participants should be able to:
- Describe sonographic, cytological and molecular tools used in the evaluation and risk assessment of thyroid nodules and their impact on patient care and patient outcomes.
- Identify less invasive, imaging-based methods in the management of thyroid nodules and/or small thyroid cancers.
- Understand new discoveries in thyroid hormone action, metabolism and transport and applications toward improved patient care.
- Identify newest practice guidelines and staging system of anaplastic thyroid cancer and understand how to implement these changes in order to improve patient care.
- Identify novel treatment opportunities for advanced thyroid cancers using emerging genomic data as well as novel cancer therapies.
- Identify emerging treatment approaches for Graves’ disease as well as Graves’ ophthalmopathy within a multidisciplinary practice.
- Understand translational studies in thyroidology that have led to novel clinical strategies for benign and malignant thyroid disease.
Disclosures of Conflict of Interest
As a sponsor accredited by the ACCME, the University of Colorado School of Medicine must ensure balance, independence, objectivity, and scientific rigor in all its sponsored educational activities. All speakers/faculty/contributors participating in a sponsored activity are expected to disclose to the provider any relevant personal financial interest or other relationship involving themselves or their spouse/partner within the last 12 months with any proprietary entity producing health care goods or services (excluding nonprofit or government organizations) related to the content of the activity.
Consistent with the University of Colorado School of Medicine policy, speakers/faculty/contributors for this activity are expected to disclose any economic or other personal interests that create, or may be perceived as creating, a conflict related to the material discussed. This policy is intended to make you aware of speaker/faculty/contributor’s interests, so you may form your own judgments about such material. In addition, consistent with University of Colorado School of Medicine policy, speakers/faculty/contributors are expected to disclose to you at the beginning of their presentation(s) any product mentioned during their presentation that is not labeled for the use under discussion or is still investigational.
Americans with Disability Act (ADA)
The ATA fully complies with the legal requirements of the ADA and the rules and regulations thereof.
AMERICAN THYROID ASSOCIATION® , ATA® , THYROID® , CLINICAL THYROIDOLOGY® , and the distinctive circular logo are registered in the U.S. Patent and Trademark Office as trademarks of the American Thyroid Association® , Inc.